Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

https://www.soho2019.com/

 

BCL-2 Inhibition in AML: High Effectiveness of Combination Therapy - Overview of Trials Combining Venetoclax and Targeted Agents (IDH, FLT3, MDM2 Inhibitors)

134 views
November 5, 2019
Comments 0
Login to view comments. Click here to Login